We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+1.78%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$3.85B
AUM Growth
-$284M
Cap. Flow
-$132M
Cap. Flow %
-3.43%
Top 10 Hldgs %
21.54%
Holding
5,768
New
656
Increased
2,740
Reduced
1,651
Closed
687

Sector Composition

Rank Sector Weight
1 Technology 21.48%
2 Financials 7.64%
3 Healthcare 7.18%
4 Consumer Discretionary 6.43%
5 Industrials 6.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GBFH
2626
GBank Financial Holdings
GBFH
$307M
$57.2K ﹤0.01%
2,138
+1,796
+525% +$55.1K
ITIC
2627
Investors Title Co
ITIC
$547M
$57.2K ﹤0.01%
263
+196
+293% +$47.2K
SATL icon
2628
Satellogic
SATL
$529M
$57.2K ﹤0.01%
10,506
-7,326
-41% -$27K
BBSI icon
2629
Barrett Business Services
BBSI
$958M
$57.1K ﹤0.01%
1,956
+147
+8% +$4.86K
HELP
2630
Cybin Inc
HELP
$485M
$57K ﹤0.01%
11,873
+9,317
+365% +$60.3K
HRZN icon
2631
Horizon Technology Finance
HRZN
$296M
$57K ﹤0.01%
13,535
+12,044
+808% +$69.8K
DNA icon
2632
Ginkgo Bioworks
DNA
$528M
$56.8K ﹤0.01%
9,269
+8,253
+812% +$68.6K
LYG icon
2633
Lloyds Banking Group
LYG
$89.5B
$56.8K ﹤0.01%
+11,287
New +$61.9K
CBK
2634
Commercial Bancgroup
CBK
$470M
$56.8K ﹤0.01%
2,181
+1,746
+401% +$44.8K
IART icon
2635
Integra LifeSciences
IART
$1.29B
$56.6K ﹤0.01%
6,005
+2,833
+89% +$31.1K
XERS icon
2636
Xeris Biopharma Holdings
XERS
$1.4B
$56.5K ﹤0.01%
9,742
-998
-9% -$6.62K
FBRT
2637
Franklin BSP Realty Trust
FBRT
$625M
$56.5K ﹤0.01%
6,651
+1,809
+37% +$17.2K
PRAA icon
2638
PRA Group
PRAA
$656M
$56.5K ﹤0.01%
3,226
+1,242
+63% +$18.9K
CLFD icon
2639
Clearfield
CLFD
$418M
$56.4K ﹤0.01%
2,130
+1,270
+148% +$38.7K
FOXF icon
2640
Fox Factory Holding Corp
FOXF
$742M
$56.2K ﹤0.01%
3,415
+1,526
+81% +$27.6K
PGY icon
2641
Pagaya Technologies
PGY
$1.58B
$56.1K ﹤0.01%
4,819
+2,381
+98% +$37.7K
FMNB icon
2642
Farmers National Banc Corp
FMNB
$940M
$56.1K ﹤0.01%
4,264
+2,856
+203% +$37.5K
LCNB icon
2643
LCNB Corp
LCNB
$283M
$56.1K ﹤0.01%
3,597
+2,927
+437% +$49K
FDMT icon
2644
4D Molecular Therapeutics
FDMT
$542M
$56K ﹤0.01%
6,018
+3,799
+171% +$33.1K
PNTG icon
2645
Pennant Group
PNTG
$1.4B
$56K ﹤0.01%
1,838
+559
+44% +$17.3K
NTLA icon
2646
Intellia Therapeutics
NTLA
$1.5B
$56K ﹤0.01%
+4,367
New +$55.6K
MMIT icon
2647
IQ MacKay Municipal Intermediate ETF
MMIT
$1.45B
$56K ﹤0.01%
2,322
+1,524
+191% +$37.3K
CPF icon
2648
Central Pacific Financial
CPF
$1.02B
$56K ﹤0.01%
1,751
-92
-5% -$2.96K
ALCO icon
2649
Alico
ALCO
$280M
$55.8K ﹤0.01%
1,353
+1,038
+330% +$41.2K
CION icon
2650
CION Investment
CION
$296M
$55.8K ﹤0.01%
8,152
+8,102
+16,204% +$68.1K

Similar funds

Tower Research Capital (TRC)'s Q1 2026 Portfolio in Review

As of Q1 2026, Tower Research Capital (TRC) held 5,768 positions worth $3.85B, down 6.9% from $4.13B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Tower Research Capital (TRC) withdrew a net $132M in Q1 2026, closing 687 positions and reducing 1,651 holdings. Its most notable exit was State Street SPDR Bloomberg Short Term High Yield Bond ETF, an estimated $58.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 30% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Core US Aggregate Bond ETF worth $39.7M.

  • Tower Research Capital (TRC)'s largest Q1 2026 buy was iShares Core US Aggregate Bond ETF: 400,371 shares worth $39.7M.
  • Tower Research Capital (TRC) added most to Invesco QQQ Trust in Q1 2026, an estimated $147M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2026 reduction was NVIDIA, cutting an estimated $104M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Bloomberg Short Term High Yield Bond ETF in Q1 2026, selling an estimated $58.1M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 22% of its $3.85B portfolio in Q1 2026.
  • Tower Research Capital (TRC) opened 656 new positions and closed 687 in Q1 2026.
  • Tower Research Capital (TRC)'s portfolio value fell 6.9% quarter-over-quarter to $3.85B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.